(Q34501941)

2 August 2017

1 reference

title

Chemoradiotherapy for cervical cancer (English)

1 reference

2 August 2017

0 references

cervix uterine cancer

1 reference

Rose PG

1

1 reference

2 August 2017

publication date

1 January 2002

1 reference

European Journal of Cancer

2 August 2017

published in

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

270-278

1 reference

2 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Clinical dose-response curves of human malignant epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Neutron therapy in cervical cancer: results of a phase III RTOG Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Analysis of Sites and Causes of Failures of Irradiation in Invasive Squamous Cell Carcinoma of the Intact Uterine Cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Chemotherapy Followed by Radiotherapy versus Radiotherapy Alone in Locally Advanced Cervical Cancer: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Concurrent chemoradiation in advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Experimental studies on schedule dependence in the treatment of cancer with combinations of chemotherapy and radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Effect of cisplatin resistance on cellular radiation response.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

5-fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

The morbidity and utility of periaortic radiotherapy in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

Paclitaxel: a radiation sensitizer of human cervical cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

[The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900352-5

7 January 2021

10.1016/S0959-8049(01)00352-5

Identifiers

DOI

1 reference

2 August 2017

1 reference